METHOD FOR PREDICTING THE EFFICACY OF A CHEMOTHERAPEUTIC REGIMEN FOR GASTRIC AND GASTROINTESTINAL CANCER USING ANTIBODIES SPECIFIC FOR...
US Application 60/007,825
Filed on 1995-12-01
Filed on 1995-12-01
METHODS FOR DETERMINING THE PROGNOSIS OF BREAST CANCER USING ANTIBODIES SPECIFIC FOR THYMIDYLATE SYNTHASE
US Application 60/008,494
Filed on 1995-12-11
Filed on 1995-12-11
ISOLATION OF AMPLIFIED GENES VIA cDNA SUBTRACTIVE HYBRIDIZATION
US Application 60/002,188
Filed on 1995-08-11
Filed on 1995-08-11
DEPIGMENTING ACTIVITY OF AGOUTI SIGNAL PROTEIN AND PEPTIDES THEREOF
US Application 60/000,436
Filed on 1995-06-23
Filed on 1995-06-23
RECOMBINANT RIBONUCLEASE PROTEINS
US Application 60/011,800
Filed on 1996-02-21
Filed on 1996-02-21
DOMINANT NEGATIVE TRANSCRIPTION REGULATORY PROTEINS CREATED BY ACIDIC AMPHIPATHIC ALPHA-HELICAL EXTENSION OF THE LEUCINE ZIPPER
US Application 60/001,654
Filed on 1995-07-31
Filed on 1995-07-31
RESTRICTION DISPLAY (RD-PCR) OF DIFFERNTIALLY EXPRESSED mRNAs
US Application 60/011,379
Filed on 1996-02-09
Filed on 1996-02-09
Multivariate Profiling of Complex Biological Regulatory Pathways
US Application 60/461,410
Filed on 2003-04-10
Filed on 2003-04-10
Establishment of the First Federal Technology Transfer Ambassadors Program
Drs. Alan Alfano, Laura Prestia, and Robert Sons, technology transfer rookies at the National Cancer Institute’s (NCI) Technology Transfer Center (TTC), established the first federal Technology Transfer Ambassadors Program (TTAP). The TTAP is a year-long, hybrid training/mentoring program for NCI post-doctoral scientists seeking professional and career development about invention development, commercialization, and entrepreneurship.
NCI TTC:
• Alan Alfano, Ph.D., TTM
• Laura Prestia, Ph.D., TTM
• Robert Sons, Ph.D., TTM
Development of Large Scale Production, Anti-HIV Microbicide in Soya Beans
HIV microbicides are not currently sold commercially, and many other HIV prevention techniques remain unavailable or unfeasible in developing countries where the disease is most prevalent. The technology transfer effort of developing large scale production methods of CV-N in soy beans helps to address this issue. The ability to produce CV-N in large quantities at low cost affords researchers the potential to develop effective HIV prevention methods worldwide.